找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Immigranten im Wohlfahrtsstaat; am Beispiel der Rech Hubert Heinelt,Anne Lohmann Book 1992 Springer Fachmedien Wiesbaden 1992 Arbeit.Besch?

[復(fù)制鏈接]
樓主: incoherent
11#
發(fā)表于 2025-3-23 12:23:19 | 只看該作者
Hubert Heinelt,Anne Lohmann therapyof T-cell prolymphocytic leukemia and T-cell large granular lymphocyte leukemia, two rare CLL-related entities, are addressed...?.978-3-030-11392-6Series ISSN 2197-9766 Series E-ISSN 2197-9774
12#
發(fā)表于 2025-3-23 15:27:20 | 只看該作者
the CLL and the aggressive lymphoma clones. Rituximab-containing polychemotherapy is the back-bone treatment in DLBCL-type RS. Young patients who respond to induction therapy should be offered stem cell transplant to prolong survival. ABVD-related regimen is the preferred regimen for the HL variant
13#
發(fā)表于 2025-3-23 21:26:29 | 只看該作者
Hubert Heinelt,Anne Lohmannd potentially resulting in overexpression of BCL2, being an early feature of the disease in the majority of patients. However, genomic studies demonstrate a large array of additional molecular abnormalities with over 40 driver mutations potentially involved in the development of progressive disease.
14#
發(fā)表于 2025-3-24 01:12:44 | 只看該作者
Hubert Heinelt,Anne Lohmannt when selecting time and type of treatment in CLL patients. We gained further knowledge on the role of B-cell receptor (BcR) signaling and accumulated several hints supporting its key role in CLL development and progression. This led, for the first time in CLL history, to a targeted treatment appro
15#
發(fā)表于 2025-3-24 04:38:45 | 只看該作者
Hubert Heinelt,Anne Lohmannd potentially resulting in overexpression of BCL2, being an early feature of the disease in the majority of patients. However, genomic studies demonstrate a large array of additional molecular abnormalities with over 40 driver mutations potentially involved in the development of progressive disease.
16#
發(fā)表于 2025-3-24 09:01:55 | 只看該作者
17#
發(fā)表于 2025-3-24 10:52:05 | 只看該作者
18#
發(fā)表于 2025-3-24 18:25:46 | 只看該作者
19#
發(fā)表于 2025-3-24 21:13:37 | 只看該作者
are recognized, namely the diffuse large B-cell lymphoma (DLBCL) variant and the rare Hodgkin lymphoma (HL) variant. Histologic documentation is mandatory to diagnose RS. In the presence of clinical features suspicious of RS, diagnosis of transformation and choice of the site of biopsy may take adva
20#
發(fā)表于 2025-3-25 01:30:10 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-25 14:11
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
滨州市| 沂南县| 资溪县| 久治县| 邵东县| 古蔺县| 河津市| 蒙阴县| 临洮县| 通化市| 奈曼旗| 乌鲁木齐县| 鲁甸县| 永丰县| 卓尼县| 衡阳县| 平顺县| 饶河县| 青龙| 邵阳县| 迁安市| 谢通门县| 晋城| 洛南县| 英吉沙县| 岗巴县| 岳西县| 称多县| 柳林县| 武陟县| 南岸区| 金塔县| 临澧县| 云浮市| 两当县| 石泉县| 定日县| 巨鹿县| 沭阳县| 息烽县| 卢湾区|